An exploratory analysis of treatment completion and client and organizational factors using hierarchical linear modeling

Evaluation and Program Planning

Volumn 29, Issue 4, 2006, Pages 335-351

  Woodward, Albert ^a   Das, Abhik ^a   Raskin, Ira E ^a   Morgan Lopez, Antonio A ^a  

^a AMERICAN COLLEGE OF CARDIOLOGY   (United States)

Author keywords

Hierarchical linear modeling; On manuscript substance abuse; Treatment completion; Treatment costs

Indexed keywords

DRUG; EMPIRICAL ANALYSIS; MODELING;

NORTH AMERICA; UNITED STATES;

EID: 33750529577     PISSN: 01497189     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.evalprogplan.2006.08.005     Document Type: Article

References (103)

1. Acharyya S., and Zhang H. Assessing sex differences on treatment effectiveness from the drug abuse treatment outcome study (DATOS). American Journal of Drug and Alcohol Abuse 29 (2003) 415-444
2. Alexander J.A., Wheeler J.R., Naira T.A., and Lemak C.H. Managed care and technical efficiency in outpatient substance abuse treatment units. Journal of Behavioral Health Services & Research 25 (1998) 377-396
3. Anderson D.W., Bowland B.J., Cartwright W.S., and Bassin G. Service-level costing of drug abuse treatment. Journal of Substance Abuse Treatment 15 (1998) 201-211
4. Barnett P.G., and Swindle R.W. Cost-effectiveness of inpatient substance abuse treatment. Health Services Research 32 (1997) 615-629
5. Borg L., Broe D.M., Ho A., and Kreek M.J. Cocaine abuse sharply reduced in an effective methadone maintenance program. Journal of Addictive Disease 18 (1999) 63-75
6. Brennan P.L., Kagay C.R., Geppert J.J., and Moos R.H. Predictors and outcomes of outpatient mental health care: A 4-year prospective study of elderly Medicare patients with substance use disorders. Medical Care 39 (2001) 39-49
7. Breslow N.E., and Clayton D.G. Approximate inference in generalized linear mixed models. Journal of the American Statistical Association 88 (1993) 9-25
8. Cacciola J.S., Dugosh K., Foltz C., Leahy P., and Stevens R. Treatment outcomes: First time versus treatment-experienced clients. Journal of Substance Abuse Treatment 28 Suppl. 1 (2005) S13-S22
9. Capital Consulting Corporation. (1993). Uniform system of accounting and cost reporting for substance abuse treatment providers (Contract No. SAMHSA 270-91-8327). Fairfax, VA: Author.
10. Capital Consulting Corporation. Summary report on assessment and measurement of treatment costs. Report for the Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration (2000), Author, Fairfax, VA
11. Carlson M.J., and Gabriel R.M. Patient satisfaction, use of services, and one-year outcomes in publicly funded substance abuse treatment. Psychiatric Services 52 (2001) 1230-1236
12. Clapp J.D. Organizational factors related to AIDS/HIB education in outpatient substance abuse treatment units. Journal of Health and Social Policy 9 (1998) 1-13
13. Clapp J.D., and Burke A.C. Supervisor ideology and organizational response: HIV/AIDS prevention in outpatient substance abuse treatment units. Administrative Social Work 21 (1997) 49-64
14. Clayton D., and Kaldor J. Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics 43 (1987) 671-681
15. Collins L.M., Schafer J.L., and Kam C.M. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychological Methods 6 (2001) 330-351
16. D'Aunno T., and Sutton R. The responses of drug abuse treatment organizations to financial adversity: A partial test of the threat-rigidity thesis. Journal of Management 18 (1992) 117-131
17. D'Aunno T., and Vaughn T.E. An organizational analysis of service patterns in outpatient drug abuse treatment units. Journal of Substance Abuse 7 (1995) 27-42
18. Dees S.M., Dansereau D.F., and Simpson D.D. A visual representation system for drug abuse counselors. Journal of Substance Abuse Treatment 11 (1994) 517-523
19. Dempster A.P., Laird N.M., and Rubin D.B. Maximum likelihood for incomplete data via the EM algorithm (with discussion). Journal of the Royal Statistical Society, Series B 44 (1977) 1-38
20. Dunlap L.J., and French M.T. A comparison of two methods for estimating the costs of drug abuse treatment. Journal of Maintenance in the Addictions 1 (1998) 29-44
21. Etheridge R.M., Craddock S.G., Hubbard R.L., and Rounds-Bryant J.L. The relationship of counseling and self-help participation to patient outcomes in DATOS. Drug and Alcohol Dependence 57 (1999) 99-112
22. Etheridge R.M., and Hubbard R.L. Conceptualizing and assessing treatment structure and process in community-based drug dependency treatment programs. Substance Use and Misuse 35 (2000) 1757-1795
23. Fiorentine R., and Anglin M.D. More is better: Counseling participation and the effectiveness of outpatient drug treatment. Journal of Substance Abuse Treatment 13 (1996) 341-348
24. Flanzer J. Health services research: Drug use and human immunodeficiency virus in the United States. Clinical Infectious Diseases 37 Supplement 5 (2003) S439-S444
25. French M.T., Dunlap L.J., Zarkin G.A., McGeary K.A., and McLellan A.T. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment, 14 (1997) 1-11
26. French M.T., Roebuck M.C., Dennis M.L., Godley S.H., Liddle H.A., and Tims F.M. Outpatient marijuana treatment for adolescents. Economic evaluation of a multisite field experiment. Evaluation Review 27 (2003) 421-459
27. French M.T., Roebuck M.C., McLellan A.T., and Sindelar J.L. Can the treatment services review be used to estimate the costs of addiction and ancillary services?. Journal of Substance Abuse 12 (2000) 341-361
28. French M.T., Salome H.J., and Carney M. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington. Social Science & Medicine 55 (2002) 2267-2282
29. French M.T., Salome H.J., Sindelar J.L., and McLellan A.T. Benefit-cost analysis of addiction treatment: Methodological guidelines and empirical application using the DATCAP and ASI. Health Services Research 37 (2002) 433-455
30. Friedmann P.D., Hendrickson J.C., Gerstein D.R., and Zhang Z. Designated case managers as facilitators of medical and psychosocial service delivery in addiction treatment programs. Journal of Behavioral Health Services & Research 331 (2004) 86-97
31. Galanter M., Keller D.S., and Dermatis H. The impact of managed care on substance abuse treatment: A report of the American Society of Addiction Medicine. Journal of Addictive Disease 19 (2000) 13-34
32. Graham J.W. Adding missing-data relevant variables to FIML-based structural equation models. Structural Equation Modeling 10 (2003) 80-100
33. Greenfield L., Burgdorf K., Chen X.W., Porowski A., Roberts T., and Herrell J. Effectiveness of long-term residential substance abuse treatment for women: Findings from three national studies. American Journal of Drug and Alcohol Abuse 30 (2004) 537-550
34. Greenfield L., and Fountain D. Influence of time in treatment and follow-up duration on methadone treatment outcomes. Journal of Psychopathology and Behavioral Assessment 27 (2000) 353-364
35. Grella C.E., Hser Y.-I., and Hsieh S.C. Predictors of drug treatment re-entry following relapse to cocaine use in DATOS. Journal of Substance Abuse Treatment 25 (2003) 145-154
36. Grella C.E., and Joshi V. Gender differences in drug treatment careers among clients in the national Drug Abuse Treatment Outcome Study. American Journal of Drug and Alcohol Abuse 25 (1999) 385-406
37. Grella C.E., Joshi V., and Hser Y.-I. Program variation in treatment outcomes among women in residential drug treatment. Evaluation Review 24 (2000) 364-383
38. Groeneveld P.W., Heidenrich P.A., and Garber A.M. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation 108 (2003) 286-291
39. Heinrich C.J., and Fournier E. Dimensions of publicness and performance in substance abuse treatment organizations. Journal of Policy Analysis & Management 23 (2004) 49-70
40. Heinrich C.J., and Lynn Jr. L.E. Improving the organization, management, and outcomes of substance abuse treatment programs. American Journal of Drug and Alcohol Abuse 28 (2002) 601-622
41. Hosmer D., and Lemeshow S. Applied logistic regression (2000), Wiley Interscience, New York
42. Hser Y., Shen H., Grella C., and Anglin M.D. Lifetime severity index for cocaine use disorder (LSI-Cocaine): A predictor of treatment outcomes. Journal of Nervous and Mental Diseases 187 (1999) 742-750
43. Hser Y.-I., Huang D., Teruya C., and Anglin M.D. Diversity of drug abuse treatment utilization patterns and outcomes. Evaluation and Program Planning 27 (2004) 309-319
44. Hser Y.-I., Joshi V., Maglione M., Chou C.-P., and Anglin M.D. Effects of program and patient characteristics on retention of drug treatment patients. Evaluation and Program Planning 24 (2001) 331-341
45. Hu T.-W., Hunkeler E.M., Weisner C., Li E., Grayson D.K., Westphal J., et al. Treatment participation and outcome among problem drinkers in a managed care alcohol outpatient treatment program. Journal of Mental Health Administration 24 (1997) 23-34
46. Hubbard R.L.., Craddock S.G., and Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcomes studies (DATOS). Journal of Substance Abuse Treatment 25 (2003) 125-134
47. Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., and Etheridge R.M. Overview of 1-year follow-up outcomes in drug abuse treatment outcome study (DATOS). Psychology of Addictive Behaviors 11 (1997) 261-278
48. Joe G.W., Simpson D.D., and Broome K.M. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 93 (1998) 1177-1190
49. Joe G.W., Simpson D.D., and Broome K.M. Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependence 57 (1999) 113-125
50. Joe G.W., Simpson D.D., and Hubbard R.L. Treatment predictors of tenure in methadone maintenance. Journal of Substance Abuse 3 (1991) 73-84
51. Knudsen H.K., Johnson J.A., and Roman P.M. Retaining counseling staff at substance abuse treatment centers: Effects of management practices. Journal of Substance Abuse Treatment 24 (2003) 129-135
52. Knudsen J.K., and Roman P.M. Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. Journal of Substance Abuse Treatment 26 (2004) 353-361
53. Korn E.L., and Graubard B.I. Estimating variance components by using survey data. Journal of the Royal Statistical Society, Series B 65 (2003) 175-190
54. Lemak C.H., and Alexander J.A. Managed care and outpatient substance abuse treatment intensity. The Journal of Behavioral Health Services & Research 28 (2001) 12-29
55. Lemak D.H., Alexander J.A., and Roy J. Why do drug treatment organizations use contingent staffing arrangements? An analysis of market and social influences. Journal of Health and Social Behavior 44 (2003) 180-197
56. Leshner A.I. Introduction to the special issue: The National Institute on Drug Abuse's (NIDA's) Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 11 (1997) 211-215
57. Leslie D.L., and Rosenheck R. Shifting to outpatient care? Mental health care use and cost under private insurance. American Journal of Psychiatry 156 (1999) 1250-1257
58. Liang K.Y., and Zeger S.L. Regression analysis for correlated data. Annual Review of Public Health 14 (1993) 43-68
59. Liu H., and Wu T. Estimating the area under a receiver operating characteristic curve for repeated measures design. Journal of Statistical Software 8 (2003)
60. Lubelczyk R.A., Friedmann P.D., Lemon S.C., Stein M.D., and Gerstein D.R. HIV prevention services in correctional drug treatment programs: Do they change risk behaviors?. AIDS Education and Prevention 14 (2002) 117-125
61. McCaughrin W.C., and Howard D.L. Variation in access to outpatient substance abuse treatment: Organizational factors and conceptual issues. Journal of Substance Abuse 8 (1996) 403-415
62. McCaughrin W.C., and Price R.H. Effective outpatient drug treatment organizations: Program features and selection effects. International Journal of Addiction 27 (1992) 1335-1358
63. McClellan A.T., Hagan T.A., Levine M., Meyers K., Gould F., Bencivengo M., et al. Does clinical case management improve outpatient addiction treatment?. Drug and Alcohol Dependence 55 (1999) 91-103
64. McClellan A.T., and McKay J.R. The treatment of addiction: What can research offer practice?. In: Lamb S., Greenlick M.R., and McCarty D. (Eds). Bridging the gap between practice and research (1998), National Academy Press, Washington, DC 147-185
65. McClellan A.T., Woody G.E., Metzger D., McKay J., Durrell J., Alterma A.I., et al. Evaluating the effectiveness of addiction treatments: Reasonable expectations, appropriate comparisons. In: Egertson J.A., Fox D.M., and Leshner A.I. (Eds). Treating drug abusers effectively (1997), Milbank Memorial Fund, Malden, MA 7-40
66. McCulloch C.E. Maximum likelihood algorithms for generalized linear mixed models. Journal of the American Statistical Association 92 (1997) 162-170
67. Mertens J.R., and Weisner C.M. Predictors of substance abuse treatment retention among women and men in an HMO. Alcohol Clinical Experiment Research 24 (2000) 1525-1533
68. Mojtabai R., and Zivin J.G. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: A propensity score analysis. Health Services Research 38 (2003) 233-259
69. Moos R.H., Mertens J.R., and Brennan P.L. Program characteristics and readmission among older substance abuse patients: Comparisons with middle-aged and younger patients. Journal of Mental Health Administration 22 (1995) 332-345
70. Morral A.R., Belding M.A., and Iguchi M.Y. Identifying methadone maintenance clients at risk for poor treatment response: Pretreatment and early progress indicators. Drug and Alcohol Dependence 55 (1999) 25-33
71. Mudano A.S., Casebeer L., and Patino F. Racial disparities in osteoporosis prevention in managed care. Southern Medical Journal 96 (2003) 445-451
72. Nietert P.J., and Silver R.M. Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA. Journal of Rheumatology 30 (2003) 1238-1243
73. O'Brien C.P., Woody G.E., and McLellan A.T. Enhancing the effectiveness of methadone using psychotherapeutic interventions. NIDA Research Monograph 150 (1995) 5-18
74. Pfeffermann D., Skinner C.J., and Holmes D.J. Weighting for unequal selection probabilities in multilevel models. Journal of the Royal Statistical Society, Series B 60 (1998) 23-40
75. Prendergast M.L., Podus D., and Chang E. Program factors and treatment outcomes in drug dependence treatment: An examination using meta-analysis. Substance Use and Misuse 35 (2000) 1931-1965
76. Price R.H., Burke A.C., D'Aunno T.A., Klingel D.M., McCaughrin W.C., Rafferty J.A., et al. Outpatient drug abuse treatment services, 1988: Results of a national survey. NIDA Research Monograph 106 (1991) 63-92
77. Rawson R.A., Huber A., Brethren P., Obert J., Gulati V., Shoptaw S., et al. Methamphetamine and cocaine users: Differences in characteristics and treatment retention. Journal of Psychoactive Drugs 32 (2000) 233-238
78. Rawson R.A., and Obert J. The substance abuse treatment system in the US What is it? What does it do? Myths and misconceptions. Occupational Medicine 17 (2001) 27-39
79. Reif S., Horgan C.M., Ritter G.A., and Tompkins C.P. The impact of employment counseling on substance user treatment participation and outcomes. Substance Use & Misuse 39 (2004) 2391-2424
80. Saxon A.J., Wells E.A., Fleming C., Jackson T.R., and Calsyn D.A. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 91 (1996) 197-209
81. Schildhaus S., Gerstein D., Brittingham A., Cerbone F.G., and Dugoni B. Services research outcomes study: Explanation of treatment effectiveness, using individual-level and programmatic variables. Substance Use & Misuse 35 (2000) 1879-1910
82. Schumacher J.E., Milby J.B., Caldwell E., Raczynski J., Engle M., Michael M., et al. Treatment outcome as a function of treatment attendance with homeless persons abusing cocaine. Journal of Addictive Disease 14 (1995) 73-85
83. Simpson D.D. Modeling treatment process and outcomes: Editorial. Addiction 96 (2001) 207-211
84. Simpson D.D., and Joe G.W. A longitudinal evaluation of treatment engagement and recovery stages. Journal of Substance Abuse Treatment 27 (2004) 89-97
85. Simpson D.D., Joe G.W., Rowan-Szal G.A., and Greener J.M. Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment 14 (1997) 565-572
86. Singh A.C., Folsom R.E., and Vaish A. A hierarchical Bayes generalization for the Fay-Herriott method to unit level non-linear mixed models for small area estimation. Proceedings of the Section on Survey Research Methods of the American Statistical Association (2002) 3258-3263
87. Singh, A. C., Folsom, R. E., & Vaish, A. K. (2003). Small area estimation from multiple surveys using the estimating function-based hierarchical Bayes method. Presented to the Joint Statistical Meetings, San Francisco.
88. Smith R. Substance abuse treatment outcomes: Treatment practice and policy implications. Journal of Psychopathology and Behavioral Assessment 22 (2000) 299-307
89. Steenrod S., Brisson A., McCarty D., and Hodgkin D. Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. Recent Developments in Alcohol 15 (2001) 51-71
90. Substance Abuse and Mental Health Services Administration. Alcohol and Drug Services Study (ADSS): The national substance abuse treatment system: facilities, clients, services, and staffing (2003), Office of Applied Studies, Rockville, MD
91. Substance Abuse and Mental Health Services Administration. Alcohol and Drug Services Study (ADSS): Methodology report: phases I, II, and III (2003), Office of Applied Studies, Rockville, MD
92. Substance Abuse and Mental Health Services Administration. (2003c). The ADSS cost study: costs of substance abuse treatment in the specialty sector. Office of Applied Studies (DHHS Publication No. SMA 03-3762, Analytic Series: A-20), Rockville, MD.
93. Substance Abuse and Mental Health Services Administration, (2003d). Treatment completion in the treatment episode data set (TEDS). The Drug and Alcohol Services Information System Report (DHHS Publication No. SMA 03-3762, Analytic Series: A-20), Rockville, MD.
94. Wheeler J.R., Fadel H., and D'Aunno T.A. Ownership and performance of outpatient substance abuse treatment centers. American Journal of Public Health 82 (1992) 711-718
95. Wheeler J.R., and Nahra T.A. Private and public ownership in outpatient substance abuse treatment: Do we have a two-tiered system?. Administrative Policy in Mental Health 27 (2000) 197-209
96. Wolfinger R., and O'Connell M. Generalized linear models: A pseudo-likelihood approach. Journal of Statistical Computation and Simulation 48 (1993) 233-243
97. Woodward, A. M., Raskin, I. E., & Blacklow, B. (forthcoming). A profile of the substance abuse treatment industry: Organization, costs, and treatment outcome. Substance Use & Misuse.
98. Wright D., Bobashev G.V., and Novak S.P. Decomposing the total variation in a nested random effects model of neighborhood, household, and individual components when the dependent variable is dichotomous: Implications for adolescent marijuana use. Drug and Alcohol Dependence 78 (2005) 195-204
99. Yasui Y., and Lele S. A regression method for spatial disease rates: An estimating function approach. Journal of the American Statistical Association 92 (1997) 21-32
100. Zarkin G.A., Dunlap L.J., Bray J.W., and Wechsberg W.M. The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment. Journal of Substance Abuse Treatment 23 (2002) 261-271
101. Zarkin G.A., Dunlap L.J., and Homsi G. The substance abuse services cost analysis program (SASCAP): A new method for estimating drug treatment services costs. Evaluation and Program Planning 27 (2004) 35-43
102. Zarkin G.A., Galinis D.N., French M.T., Fountain D.L., Ingram P.W., and Guyett J.A. Financing strategies for drug abuse treatment programs. Journal of Substance Abuse Treatment 12 (1995) 385-399
103. Zhang Z., Friedmann P.D., and Gerstein D.R. Does retention matter? Treatment duration and improvement in drug use. Addiction 98 (2003) 673-684